Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-02-07
2009-10-06
Saeed, Kamal A (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S235000
Reexamination Certificate
active
07598281
ABSTRACT:
The present invention comprises compounds and compositions for the treatment of metabolic disorders and more particularly, those insulin-related metabolic disorders of the blood such as hyperlipidemia, diabetes, insulin-resistence and the like comprising acetic acid derivatives with arylcycloalkyl-substituted alkanoic acid derivatives and their salts. Known as peroxisome proliferator-activated receptors (PPAR) agonists/antagonists, the invention relates to compounds of the formula Iwherein the various substituent R-groups are more specifically defined herein.
REFERENCES:
patent: 2001/0008898 (2001-07-01), Tomiyama et al.
patent: WO 00/64876 (2000-11-01), None
patent: WO 03/020269 (2003-03-01), None
patent: WO 2004/076427 (2004-09-01), None
Morissette et al. Advanced Drug Delivery Reviews 2004, 56, 275-300.
Vippagunta et al., abstract, Vippagunta, Sudha R. “Crystalline Solids.” Advanced Drug Delivery Reviews 48(2001): 3-26.
El-Hage, Jeri. Retrieved online Sep. 9, 2008: URL: http://www.fda.gov/cder/present/DIA2006/El-Hage—Safety.pdf.
Zips et al. “New Anticancer Agents: In Vitro and In Vivo,” In Vivo, 2005, 19, 1-7.
Megard et al. “A co-culture based model of human blood-brain barrier: application to active transport of indinavir and in-vivo-in-vitro correlation,” Brain Research 927, 2002, 153-167.
“Alzheimer's.” Fact Sheet Alzheimer's Association, 2 pages.
“Alzheimer's Disease,” Retrived online via the Internet, URL: http://www.mayoclinic.com/health/alzheimers-disease/DS00161/DSECTION=3.
Falk Eugen
Glombik Heiner
Keil Stefanie
Knieps Stephanie
Schaefer Hans-Ludwig
Bell Craig
Lin Jiang
Saeed Kamal A
Sanofi-Aventis Deutschland GmbH
Shterengarts Samantha L
LandOfFree
Arylcycloakyl-substituted alkanoic acid derivatives useful... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Arylcycloakyl-substituted alkanoic acid derivatives useful..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Arylcycloakyl-substituted alkanoic acid derivatives useful... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4073146